Source: Annual Congress 2011 - Recent developments in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tanga, A. Saidi, S. Dallet-Choisy, M. L. Zani, T. Moreau (Tours, France). LSC 2011 Abstract: Inflammation and COPD: Protective effect of the recombinant anti-protease trappin-2 A62L, on lung epithelium. Eur Respir J 2011; 38: Suppl. 55, 415

Member's Comments

No comment yet.

Related content which might interest you: Lung injury and apoptosis in COPD: Effect of a recombinant anti-protease derived from trappin-2 Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Anti-inflammatory effects of the novel phosphodiesterase type 4 inhibitor CHF6001 on COPD alveolar macrophages and lung tissue Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Inhibitors of apoptosis proteins in asthmatic airway inflammation Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Expression and function of a novel membrane-spanning protein, MS4A8B, in the human airways Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Macrophage phenotype does not affect protease anti-protease imbalance in COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Macrophage migration inhibitory factor (MIF), a biomarker in COPD? Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Vitamin D increases anti-microbial activity in human airway epithelial cells Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 LSC 2010 Abstract: Dynamics of inflammation and lung functioning in murine ozone model of COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Characterization of M1 and M2 macrophages in human lung tissue Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014